Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3373 |  ACIU AC Immune SA - Common Stock | 2.55 USD | -0.78% | -10.21% | -6.59% | -27.14% | 259.44 M USD | ||
| 3383 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -0.93% | -8.97% | -11.98% | +32.30% | 255.22 M USD | ||
| 3387 |  STRO Sutro Biopharma, Inc. - Common Stock | 15.32 USD | +4.50% | -5.14% | -14.94% | -11.90% | 254.02 M USD | ||
| 3391 |  PALI Palisade Bio, Inc. - Common Stock | 1.45 USD | -2.03% | -0.68% | -29.27% | -14.71% | 252.69 M USD | ||
| 3420 |  IMRX Immuneering Corporation - Class A Common Stock | 3.74 USD | -3.11% | -8.78% | -17.44% | -40.35% | 241.97 M USD | ||
| 3450 |  EVMN Evommune, Inc. Common Stock | 6.40 USD | +2.89% | -10.86% | -39.05% | -63.05% | 232.27 M USD | ||
| 3454 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.82 USD | -7.14% | +8.98% | +62.50% | +100.00% | 231.60 M USD | ||
| 3459 |  KROS Keros Therapeutics, Inc. - common stock | 11.64 USD | +3.84% | +2.28% | +4.30% | -22.91% | 230.79 M USD | ||
| 3470 |  MGNX MacroGenics, Inc. - Common Stock | 3.55 USD | 0.00% | -2.47% | -12.99% | +100.56% | 226.14 M USD | ||
| 3471 |  ALEC Alector, Inc. - Common Stock | 2.02 USD | +5.21% | +5.76% | -9.01% | -36.08% | 225.55 M USD | ||
| 3481 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.14 USD | -1.62% | -14.22% | +4.13% | +33.86% | 222.23 M USD | ||
| 3484 |  SION Sionna Therapeutics, Inc. - Common Stock | 4.90 USD | +1.66% | -5.59% | -33.78% | -87.54% | 221.54 M USD | ||
| 3492 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.70 USD | -0.37% | -0.37% | +2.27% | -7.53% | 217.54 M USD | ||
| 3499 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 8.79 USD | +2.69% | -7.96% | -30.79% | -63.66% | 215.40 M USD | ||
| 3500 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 5.53 USD | -1.43% | +0.73% | -21.00% | -20.66% | 215.32 M USD | ||
| 3513 |  NAGE Niagen Bioscience, Inc. - Common Stock | 2.66 USD | -2.21% | -2.21% | -12.21% | -46.59% | 210.48 M USD | ||
| 3530 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.82 USD | +2.10% | -6.83% | -20.05% | -25.55% | 206.34 M USD | ||
| 3531 |  IVVD Invivyd, Inc. - Common Stock | 0.70 USD | -4.11% | -15.66% | -10.26% | -65.00% | 206.33 M USD | ||
| 3540 |  ADCT ADC Therapeutics SA Common Shares | 1.59 USD | +11.97% | +44.55% | +29.27% | -65.05% | 202.99 M USD | ||
| 3547 |  CGEN Compugen Ltd. - Ordinary Shares | 2.12 USD | -1.40% | -9.40% | -14.52% | +8.72% | 200.45 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |